The edited CYP1A1 enhanced the interaction with heme oxygenase-1 (HO-1) and mediated the nuclear translocation of HO-1 to confer resistance to oxidant stress, which promoted cell proliferation and tumor progression in NSCLC. The gene discussed is CYP1A1; the disease is neoplasm.